Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Bernstein SocGen Group raised its price target for Regeneron Pharmaceuticals to $925 from $916 while retaining an Outperform rating, citing a solid quarter, robust cash flow and profitability metrics, and upcoming Phase 3 melanoma data for the company’s LAG3 inhibitor. Other firms have also updated targets following Regeneron’s fourth-quarter 2025 …
Saudi Arabia's stock market closed higher on Monday, with the Tadawul All Share index up 1.38% as gains in several sectors outpaced declines. Leading individual advances included Saudi Pharmaceutical Appliances, Rasan Information Technology - which reached an all-time high - and Knowledge Economic City, while select mining and industrial names lagg…
JPMorgan raised its price target on Chevron to $181 from $176 while retaining an Overweight rating, highlighting cost-savings targets tied to structural reductions and post-merger investment positioning. The bank pointed to debottlenecking at major projects and a geographically diversified upstream portfolio as potential catalysts, while recent ear…
H.C. Wainwright has reaffirmed a Buy rating and a $40.00 12-month price target on Summit Therapeutics plc (NASDAQ:SMMT) after the U.S. Food and Drug Administration accepted the company’s Biologics License Application for ivonescimab. The price target implies a roughly 176% upside from Summit’s recent trading level near its 52-week low. The FDA set …
Investment bank Mizuho raised its price target on AXIS Capital (NYSE: AXS) to $141.00 from $133.00 and kept an Outperform rating, citing robust end-of-2025 operating trends. The upgrade reflects accelerating premium growth, stable underlying loss ratios, nearly $900 million of share buybacks by year-end and improved prior-year loss development, alo…
JPMorgan raised its price target on ExxonMobil to $140 from $133 and kept an Overweight rating after the company posted stronger-than-expected fourth-quarter 2025 results. Earnings per share and operating cash flow exceeded both the bank's and consensus forecasts, and ExxonMobil completed a suite of major 2025 projects expected to add roughly $3 bi…
JPMorgan reiterated an Overweight rating and a $510.00 price target on Carvana (NYSE: CVNA), highlighting the firm’s early and sustained focus on online-only used-vehicle retailing as a structural advantage. The stock, trading at $401.11, implies roughly 27% upside to JPMorgan’s target despite a recent drop of over 15% in the past week. The bank no…
H.C. Wainwright has reaffirmed a Buy rating and an $18.00 price target on Coya Therapeutics (NASDAQ:COYA) after the company completed a private placement that generated roughly $11.1 million in gross proceeds. The analyst house views the financing as extending Coya’s operational runway into late 2027 and highlights investor support from Dr. Reddy’s…
H.C. Wainwright initiated coverage of Hut 8 Mining Corp. (HUT) with a Buy rating and set a $80.00 price target. The firm highlighted the company's pivot toward digital infrastructure through long-term data center agreements, notably deals with Fluidstack and Anthropic, and emphasized Google’s financial support for the River Bend project as a credit…
Morgan Stanley increased its price target on Colgate-Palmolive Co. (CL) to $100 from $87 while keeping an Overweight rating, highlighting mid-single-digit organic growth in emerging markets that helped drive 3.1% fourth-quarter organic sales excluding pet-product discontinuations. The stock trades near $90.29, with momentum indicators signaling ove…
Needham has reiterated a Buy rating on JFrog with a $70 price target, highlighting the company's position in software supply-chain security. Trading at $54.80, the shares imply about 28% upside per InvestingPro data. Multiple sell-side firms maintain constructive views as the company prepares to report fourth-quarter results amid recent security di…
Wedbush has placed Take-Two Interactive on its Best Ideas List, keeping an Outperform rating and a $300 price target while arguing the market overreacted to a sell-off tied to Google’s Project Genie announcement. The firm says Project Genie is a complement rather than a competitor to Take-Two’s high-margin, "Hyper-Premium" content and highlights va…
U.S. stock futures opened lower Monday as a pullback in precious metal prices dampened investor sentiment ahead of a packed week of corporate earnings from major technology firms and the monthly jobs report. Notable premarket movers included gains for Oracle, Disney, and Autodesk, while Nvidia, Tesla, a group of gold miners, EchoStar, Coinbase and …
Oracle shares reversed an early drop and climbed after Fitch Ratings affirmed the company’s issuer ratings and assigned a 'BBB' rating to its proposed benchmark unsecured bonds. The move comes amid Oracle's plans to raise $45 billion to $50 billion through debt and equity to fund AI compute infrastructure, capital expenditures, debt repayment and p…
Evercore ISI strategists led by Julian Emanuel view the recent sharp drop in gold and silver - following what they describe as frantic, meme-like trading - as unlikely to present a material headwind for equities. The firm notes that parabolic price action across a range of assets in early 2026 reflects stretched trends, and that the subsequent reve…
Guggenheim reiterated a Buy rating and a $51.00 price target on DBV Technologies after meetings with company leadership, noting alignment with regulators and recent positive clinical readouts. The stock has surged 411% over the past year; DBV is preparing for an important earnings update on March 5 amid ongoing regulatory and commercial execution r…
Leerink Partners increased its price objective for NeuroPace Inc. (NPCE) to $20 from $19 while retaining an Outperform rating, pointing to continued commercial traction for the company's Responsive Neurostimulation (RNS) system and the prospect of FDA approval for idiopathic generalized epilepsy in the second half of 2026 as a potential transformat…
Guggenheim has reaffirmed a Buy rating on Oracle with a $400 price objective and designated the company its Best Idea heading into 2026. The call accompanies Oracle's plan to raise $45-50 billion in gross proceeds to accelerate Oracle Cloud Infrastructure growth for major customers, even as investors weigh capital intensity and the stock trades far…
Guggenheim has reaffirmed a Buy rating and a $38.00 price objective for Pinterest Inc (PINS) after examining the company's January 2026 audience reach and app download figures. The price target implies roughly 72% upside from the current share price, even as core audience reach and domestic downloads showed weakness. Pinterest is initiating a globa…
Revvity reported fourth-quarter results that outpaced analyst estimates and provided 2026 guidance for adjusted EPS and revenue that exceed consensus. Management highlighted durability in the diagnostics business even as academic research funding remains subdued, and pointed to broader improvements in the pharmaceutical market and reduced policy un…
Cboe Global Markets is in preliminary discussions with retail broker-dealers and market makers to relaunch binary options for individual investors. The proposed fixed-return contracts would pay a set amount or nothing, allowing traders to place yes-or-no bets on discrete outcomes. If launched, the product would compete directly with prediction-mark…
Stephens’ 2026 Best Ideas in Financials list concentrates on regional banks and specialty finance firms where internal operations, balance-sheet repositioning and current valuations are seen as stronger drivers of returns than the uncertain macro backdrop. The selections prioritize margin expansion, funding relief and identifiable self-help catalys…
ServiceNow's Now Platform is increasingly central to enterprise automation and AI-driven workflows. Q4 results show $3.57B revenue and 21% YoY growth, while balance sheet strength and $4.58B free cash flow give the company runway to integrate recent AI-focused acquisitions. The stock is materially oversold (RSI ~25) and trading near its 52-week low…
The administration is announcing Project Vault, a $12 billion public-private effort to acquire and store critical minerals to lessen U.S. dependence on Chinese supply chains and protect domestic manufacturers from potential disruptions. Financing will include $10 billion from the U.S. Export-Import Bank and $1.67 billion in private capital; purchas…
The National Highway Traffic Safety Administration has expanded its safety investigation to include roughly 1.27 million Ford F-150 pickup trucks from the 2015-2017 model years following owner complaints of abrupt downshifts and intermittent transmission sensor signal loss that can cause sudden deceleration or rear-wheel lockup. Preliminary testing…
